Detalhe da pesquisa
1.
Evaluation of 2D and 3D Erythroid Differentiation Protocols Using Sickle Cell Disease and Healthy Donor Induced Pluripotent Stem Cells.
Cells
; 12(8)2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190030
2.
Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report.
Front Med (Lausanne)
; 8: 767291, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34869480
3.
Generation of human iPS cell line CBTCi001-A from dermal fibroblasts obtained from a healthy donor.
Stem Cell Res
; 41: 101630, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31706097
4.
Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency.
Stem Cell Res
; 39: 101488, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272037
5.
Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies.
Stem Cell Res
; 38: 101454, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078962
6.
Generation of integration-free iPS cell lines from three sickle cell disease patients from the state of Bahia, Brazil.
Stem Cell Res
; 33: 10-14, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296668